SN38 PLGA nanoparticles provide sustained antitumor efficacy and ameliorate colitis severity in a murine colitis-associated cancer model.

Saved in:
Bibliographic Details
Title: SN38 PLGA nanoparticles provide sustained antitumor efficacy and ameliorate colitis severity in a murine colitis-associated cancer model.
Authors: Weng MT; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, Taiwan., Liu SY; Liver Disease Prevention & Treatment Research Foundation, Taipei, Taiwan., Hsiung CY; Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, Taiwan.; Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan., Wu MC; Liver Disease Prevention & Treatment Research Foundation, Taipei, Taiwan., Lee TY; Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, Taiwan., Lin BR; Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan., Chen Y; Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, Taiwan.; Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan., Wei SC; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
Source: International journal of pharmaceutics: X [Int J Pharm X] 2026 Apr 27; Vol. 11, pp. 100552. Date of Electronic Publication: 2026 Apr 27 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101753452 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-1567 (Electronic) Linking ISSN: 25901567 NLM ISO Abbreviation: Int J Pharm X Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2590-1567
DOI:10.1016/j.ijpx.2026.100552